Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Desert Gold Report Results from 3,900 Meter Phase 2 Exploration Drill Program (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Healthcare Biotechnology
Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > 6 sedar reports
View:
Post by m8magic on Dec 02, 2020 6:49pm

6 sedar reports

filed today..ceo.ca has them
Comment by YegJeeber on Dec 02, 2020 8:15pm
Not for Oncolytics Biotech
Comment by canadafan on Dec 02, 2020 8:54pm
Actually SeDI reports not SEDAR The SEDI reports are for insider buying. They utilized thier Dec share rights and bought on the open market about 3000 shares each. Not huge, but that is the number based on thier year end "share purchse optoins" They could & did , yesterday... Not sure why it says "6 reports  issued" as it only seemed to be one. Unless there are Sedar ...more  
Comment by m8magic on Dec 02, 2020 9:58pm
thanx for all the info canadafan....and the great insight of he potential value,,
Comment by Lesalpes29 on Dec 03, 2020 8:18am
An easy way To find All Sedi reports is To go on ceo.ca with the ticker ONC. Have a good Day.
Comment by westcoast1000 on Dec 03, 2020 12:47pm
CF, Thanks for the update. Also checked on INK and it shows they all have large quantities of options.
Oncolytics Biotech Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities